捷安高科: 关于2022年限制性股票激励计划首次授予部分第三个归属期归属结果暨股份上市的公告

Core Viewpoint - The announcement details the results of the first batch of stock vesting under the 2022 Restricted Stock Incentive Plan, highlighting the fulfillment of vesting conditions for 45 incentive targets and the upcoming listing of shares. Summary by Sections Incentive Plan Overview - The 2022 Restricted Stock Incentive Plan was approved in meetings held on April 25 and May 16, 2022, with the main content outlined in the plan [2][3]. - The plan includes a total of 1,509,225 shares for 45 incentive targets, with vesting occurring in batches [2][4]. Vesting Conditions - The vesting conditions require that the company does not face any negative audit opinions or fail to distribute profits as per regulations [5][6]. - The performance assessment period spans from 2022 to 2024, with specific revenue and net profit growth targets set for each year [20][21]. Stock Vesting Details - The first batch of shares to vest includes 1,423,612 shares, which represents a portion of the total stock granted [4][22]. - The shares will be listed for trading on July 15, 2025, and the adjusted grant price is set at 3.52 yuan per share [22][24]. Compliance and Restrictions - The incentive targets must adhere to specific trading restrictions, including limitations on share transfers during their tenure and a six-month restriction post-termination [23][24]. - The company has established compliance measures to prevent insider trading and ensure the integrity of the incentive plan [22][23].